Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lipopolysaccharide induces acute lung injury and alveolar haemorrhage in association with the cytokine storm, coagulopathy and AT1R/JAK/STAT augmentation in a rat model that mimics moderate and severe Covid-19 pathology.
Al-Ani B, ShamsEldeen AM, Kamar SS, Haidara MA, Al-Hashem F, Alshahrani MY, Al-Hakami AM, Kader DHA, Maarouf A. Al-Ani B, et al. Among authors: maarouf a. Clin Exp Pharmacol Physiol. 2022 Apr;49(4):483-491. doi: 10.1111/1440-1681.13620. Epub 2022 Feb 9. Clin Exp Pharmacol Physiol. 2022. PMID: 35066912
Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury.
Dawood AF, Maarouf A, Alzamil NM, Momenah MA, Shati AA, Bayoumy NM, Kamar SS, Haidara MA, ShamsEldeen AM, Yassin HZ, Hewett PW, Al-Ani B. Dawood AF, et al. Among authors: maarouf a. Biomedicines. 2022 Jul 8;10(7):1644. doi: 10.3390/biomedicines10071644. Biomedicines. 2022. PMID: 35884947 Free PMC article.
Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus: Metformin Inhibits Femoral Artery Ultrastructural Alterations as well as Vascular Tissue Levels of AGEs/ET-1 Axis-Mediated Inflammation and Modulation of Vascular iNOS and eNOS Expression.
Shati AA, Maarouf A, Dawood AF, Bayoumy NM, Alqahtani YA, A Eid R, Alqahtani SM, Abd Ellatif M, Al-Ani B, Albawardi A. Shati AA, et al. Among authors: maarouf a, a eid r. Biomedicines. 2023 Jan 26;11(2):361. doi: 10.3390/biomedicines11020361. Biomedicines. 2023. PMID: 36830898 Free PMC article.
Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase.
Tishova Y, Kalinchenko S, Mskhalaya G, Hackett G, Livingston M, König C, Strange R, Zitzmann M, Mann A, Maarouf A, Ramachandran S. Tishova Y, et al. Among authors: maarouf a. Diabetes Obes Metab. 2024 Jun;26(6):2147-2157. doi: 10.1111/dom.15520. Epub 2024 Mar 3. Diabetes Obes Metab. 2024. PMID: 38433502 Clinical Trial.
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.
Graille-Avy L, Boutiere C, Rigollet C, Perriguey M, Rico A, Demortiere S, Durozard P, Hilezian F, Vely F, Bertault-Peres P, Pelletier J, Maarouf A, Audoin B. Graille-Avy L, et al. Among authors: maarouf a. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200231. doi: 10.1212/NXI.0000000000200231. Epub 2024 Apr 16. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38626360 Free PMC article.
Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.
Demortiere S, Joubert B, Benaiteau M, Hilezian F, Boutiere C, Rico A, Stolowy N, Dubois V, Audoin B, Maarouf A, Pelletier J. Demortiere S, et al. Among authors: maarouf a. Neurology. 2024 Apr 23;102(8):e209284. doi: 10.1212/WNL.0000000000209284. Epub 2024 Mar 25. Neurology. 2024. PMID: 38527243 No abstract available.
167 results